Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review.

Hurot JM, Cucherat M, Haugh M, Fouque D.

J Am Soc Nephrol. 2002 Mar;13(3):708-14. Review.

2.

L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?

Steinman TI, Nissenson AR, Glassock RJ, Dickmeyer J, Mattern WD, Parker TF 3rd, Hull AR.

Nephrol News Issues. 2003 Apr;17(5):28-30, 32-4, 36 passim. Review.

PMID:
12715624
4.

Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.

Brass EP, Adler S, Sietsema KE, Hiatt WR, Orlando AM, Amato A; CHIEF Investigators.

Am J Kidney Dis. 2001 May;37(5):1018-28.

PMID:
11325685
5.

Effect of dialysate composition on the lipid response to L-carnitine supplementation.

Zilleruelo G, Novak M, Hsia SL, Goldberg R, Abitbol C, Monkus E, Strauss J.

Kidney Int Suppl. 1989 Nov;27:S259-63.

PMID:
2699997
6.
7.

The role of oral L-carnitine therapy in chronic hemodialysis patients.

Sabry AA.

Saudi J Kidney Dis Transpl. 2010 May;21(3):454-9.

8.

Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.

Semeniuk J, Shalansky KF, Taylor N, Jastrzebski J, Cameron EC.

Clin Nephrol. 2000 Dec;54(6):470-7.

PMID:
11140808
9.

Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients.

Bellinghieri G, Santoro D, Calvani M, Savica V.

J Ren Nutr. 2005 Jan;15(1):13-7.

PMID:
15648000
10.

Quality of life during and between hemodialysis treatments: role of L-carnitine supplementation.

Sloan RS, Kastan B, Rice SI, Sallee CW, Yuenger NJ, Smith B, Ward RA, Brier ME, Golper TA.

Am J Kidney Dis. 1998 Aug;32(2):265-72.

PMID:
9708611
11.

L-carnitine in dialysis patients.

Ahmad S.

Semin Dial. 2001 May-Jun;14(3):209-17. Review.

PMID:
11422928
12.

Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis.

Lilien MR, Duran M, Quak JM, Frankhuisen JJ, Schröder CH.

Pediatr Nephrol. 2000 Nov;15(1-2):17-20.

PMID:
11095004
13.

The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.

Kavukçu S, Türkmen M, Salman S, Onvural B, Oktay G, Karaman O, Cevik NT.

Turk J Pediatr. 1998 Jan-Mar;40(1):79-84.

PMID:
9673532
14.

Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.

Wanner C, Wieland H, Wäckerle B, Boeckle H, Schollmeyer P, Hörl WH.

Kidney Int Suppl. 1989 Nov;27:S264-8.

PMID:
2636668
15.

Effects of L-carnitine on dialysis-related hypotension and muscle cramps: a meta-analysis.

Lynch KE, Feldman HI, Berlin JA, Flory J, Rowan CG, Brunelli SM.

Am J Kidney Dis. 2008 Nov;52(5):962-71. doi: 10.1053/j.ajkd.2008.05.031. Epub 2008 Aug 15. Review.

PMID:
18706751
16.

Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.

Attallah N, Osman-Malik Y, Frinak S, Besarab A.

Am J Kidney Dis. 2006 Apr;47(4):644-54.

PMID:
16564942
17.
18.

Carnitine replacement in end-stage renal disease and hemodialysis.

Calvani M, Benatti P, Mancinelli A, D'Iddio S, Giordano V, Koverech A, Amato A, Brass EP.

Ann N Y Acad Sci. 2004 Nov;1033:52-66. Review.

PMID:
15591003
19.

Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.

Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M, Nakai S, Miwa M, Morita H, Miwa T, Amano I, Maeda K.

Am J Kidney Dis. 1998 Aug;32(2):258-64.

PMID:
9708610
20.

Effect of L-carnitine supplementation on red blood cells deformability in hemodialysis patients.

Nikolaos S, George A, Telemachos T, Maria S, Yannis M, Konstantinos M.

Ren Fail. 2000 Jan;22(1):73-80.

PMID:
10718283

Supplemental Content

Support Center